abm | Lin28 Positive Hela Cells | T2022

abm | Lin28 Positive Hela Cells | T2022

ABM’s Lin28 Positive Hela Cells has been proven to have high Lin28 expression in human cervical adenocarcinoma cells.

Biosafety:

II

Organism:

Human

Source Organ:

N/A

Growth Properties:

N/A

Morphology:

Epithelial-like

Clones:

N/A

Passage Number:

N/A

Population Doner:

N/A

Seeding Density:

Thaw entire contents into an appropriate T25 flask as specified in the Propagation instructions.

Markers:

N/A

Applications:

ABM’s Lin28 Positive Hela Cells are suitable for many cellular applications such as flow cytometry.

Doner Gender:

N/A

Donor Ethnicity:

N/A

Knockdown Method:

N/A

Induction:

N/A

Overexpression:

N/A

Freeze Thaw:

N/A

Propagation:

Grow cells in T25 ECM-coated flasks G299) with the following conditions. The base medium for this cell line is Prigrow IV medium available at abm, To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%, and Penicillin/Streptomycin Solution: 5%, Temperature: 37.0°C.

Preservation:

N/A

Quality Control:

N/A

Tumorgenicn:

N/A

Shipping Conditions:

Cells are shipped alive in T25 flasks and are guaranteed to have high Lin28 expression for 7 days after arrival.

Storage Contidions:

-180°C